Showing results (591-600 of 622) with videos related to

Sort By:
Pageof 63
Annals of Intensive Care|November 26, 2021
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort studyGerard Moreno, Raquel Carbonell, Ignacio Martin-Loeches, et al.
The Lancet. Oncology|November 18, 2017
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trialMiguel Martin, Frankie A Holmes, Bent Ejlertsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2015
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 StudyMiguel Martín, Amparo Ruiz Simón, Manuel Ruiz Borrego, et al.
Breast (Edinburgh, Scotland)|November 26, 2020
Palbociclib combined with endocrine therapy in heavily pretreated HR<sup>+</sup>/HER2<sup>-</sup> advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)Luis Manso, Cristina Hernando, María Galán, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 20, 2021
Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancerDora Romaguera, Sílvia Fernández-Barrés, Esther Gracia-Lavedán, et al.
The New England Journal of Medicine|December 16, 2021
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast CancerKevin Kalinsky, William E Barlow, Julie R Gralow, et al.
Breast Cancer Research : BCR|June 25, 2026
Breastfeeding shapes a unique tumor-immune landscape in pregnancy-associated breast cancer from GEICAM-EMBARCAM studyRegina Peña-Enríquez, Ángel Guerrero-Zotano, Begoña Bermejo, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvementNerea Iniesta Arandia, Gerard Espinosa, Carles Tolosa Vilella, et al.
Journal of the National Cancer Institute|May 29, 2008
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancerMiguel Martín, Alvaro Rodríguez-Lescure, Amparo Ruiz, et al.
Critical Care (London, England)|February 16, 2021
Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in SpainAlejandro Rodríguez, Manuel Ruiz-Botella, Ignacio Martín-Loeches, et al.
Pageof 63